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Neurons are submitted to an exceptional variety of stimuli and are able to convert these into high-order func-
tions, such as storing memories, controlling behavior, and governing consciousness. These unique proper-
ties are based on the highly flexible nature of neurons, a characteristic that can be regulated by the complex
molecular machinery that controls gene expression. Epigenetic control, which largely involves events of
chromatin remodeling, appears to be one way in which transcriptional regulation of gene expression can
be modified in neurons. This review will focus on how epigenetic control in the mature nervous system
may guide dynamic plasticity processes and long-lasting cellular neuronal responses. We outline the molec-
ular pathways underlying chromatin transitions, propose the presence of an ‘‘epigenetic indexing code,’’ and
discuss how central findings accumulating at an exponential pace in the field of epigenetics are conceptually
changing our perspective of adult brain function.The ability to store information over long periods of time lies at
the heart of cellular identity. This cellular ‘‘memory’’ is encoded
in the specific pattern of expressed genes and allows a cell to
ensure that it ‘‘remembers’’ who it is and how it should move
along elaborate pathways during cellular development and
differentiation. During development, germ cells or totipotent
stem cells give rise to a diverse array of specialized cell types,
including nerve cells, which become more hard-wired. These
changes allow specialized cells to appropriately function in their
specific niche—and, in the case of nerve cells, allows them to
properly control cognitive and behavioral functions. Once
cellular differentiation processes are established, postmitotic
nerve cells become committed to a variety of highly specialized
functions that collectively determine our responses to external
stimuli. Yet, insults, injury, and neurodegenerative diseases
can dramatically affect nerve cells, calling into place a poorly
understood ‘‘reprogramming process’’ that may be able to erase
previously established cellular settings and, possibly, dediffer-
entiate or revert these cells to a more primitive pluripotent state.
Thus, it seems that developmental processes require ‘‘forward’’
differentiation with a built-in memory component as well as
a ‘‘reversible’’ reprogramming capability, allowing for plasticity
at many levels (anatomical, electrical, synaptic, etc.). How could
one relatively fixed genetic blueprint permit this flexibility to
accommodate variability resulting from signals originated from
environmental, dietary, and other influences?
How are cellular memories shaped by past experiences and
environmental cues? Does a molecular ‘‘sculpturing’’ process
exist during development and adult life that takes adaptive
cues from the environment (i.e., epigenetic mechanisms), or is
this molding process purely stochastic in nature with selection
doing the rest (i.e., genetic mechanisms)? (Figure 1) The nervoussystem is characterized by a vast spectrum of cell types as well
as a staggering number of reinforcing connections (synapses)
that collectively shape and translate our daily experiences into
complex thoughts and behaviors. Can 25,000 genes in our
relatively fixed human genome explain who we are and how
we act? A wealth of accumulating evidence suggests that there
is much more to the genome than DNA sequence, permitting
variability beyond the Watson-Crick DNA double helix. One
way that such additional variability can be established is through
epigenetic mechanisms (Figure 1). In this review, we explore the
evidence that suggests that these mechanisms play a critical
role in regulating neuronal function in the adult brain.
Epigenetics: An Old Word Takes on New Meaning
and Renewed Interest
A wealth of recent work from many laboratories has rekindled an
interest in an old word: epigenetics. The general concept of an
‘‘epigenetic landscape’’ was first articulated by developmental
biologist Conrad Waddington, who used it to explain how iden-
tical genotypes could unfold a wide collection of phenotypes
as development proceeded (Waddington, 1957). With time,
Waddington’s concept of a phenotypic landscape took on addi-
tional meaning: ‘‘potentially heritable changes in gene expres-
sion that do not involve changes in DNA sequence’’ (Holliday
and Pugh, 1975; Chambon, 1978; Jaenisch and Bird, 2003).
While important questions remain, Waddington’s landscape
has taken a clearer molecular form with the documentation of
a remarkable number of multisubunit complexes that act to
remodel chromatin—to exchange specific histones (histone vari-
ants) in and out of assembled chromatin—or to enzymatically
modify DNA and histones to bring about downstream events. It
is not fully clear how these dedicated machines are guided toNeuron 60, December 26, 2008 ª2008 Elsevier Inc. 961
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ReviewFigure 1. Genetic versus Epigenetic Control
Regulation of biological processes can be
achieved via genetic and epigenetic programs.
Variation in genetic information is obtained by
mutagenesis of the DNA sequence that irreversibly
changes the encoded message. Epigenetic
control operates either on DNA, via DNA methyla-
tion, or on chromatin. Variation in the chromatin
template can be brought about by posttransla-
tional modifications (PTMs; colored beads) added
to histones, exchange and replacement of major
histones with specialized variants (colored
wedges), or ATP-dependent nucleosome remod-
eling (not depicted), which alters histone:DNA
contacts. All of these mechanisms, along with
DNA methylation and potential interactions with
noncoding RNAs (not depicted), likely act together
to bring about the plasticity that helps to define
epigenetic phenomena. PTMs of histones occur
at highly conserved residues of the N-terminal tails
of the core histones (see Figure 3) and include
acetylation, methylation, phosphorylation, ubiqui-
tination, etc. Examples of combined DNA methyl-
ation and histone modifications have been
reported.their target sequences, but it is likely to involve constellations of
cis-acting regulatory proteins and noncoding RNAs that engage
the DNA template directly (Bernstein and Allis, 2005). Some
epigenetic marks, such as DNA methylation, appear to provide
more stable, if not permanent, indexing marks that extend over
long chromosomal domains, giving rise to ‘‘memorized’’ states
of gene expression that may be inherited from one cell genera-
tion to the next (Figure 1). Other modifications, such as histone
acetylation, may be more labile and mediate regulation of gene
expression over shorter-term periods. Considering the stag-
gering complexity of neurogenesis, to what extent do changes
in synaptic connections, guided by experiences, environment,
diet, etc., influence the epigenomes of postmitotic nerve cells
that underlie animal behavior, normal or abnormal? Chromatin
remodeling in the nervous system would not be directly heritable.
Rather, heritability at this level could be through the reproduc-
ibility of behavioral patterns from a parent on its offspring.
In this review, we concentrate on emerging findings that tie
epigenetic pathways to the special requirements exhibited by
nerve cells, specifically of having seemingly opposing mecha-
nisms allowing for cellular ‘‘memory’’ as well as cellular ‘‘plas-
ticity.’’ Somewhat a reflection of our interests in chromatin re-
modeling, we focus our remarks on specific examples of how
histone posttranslational modifications (PTMs) are ‘‘written,’’
‘‘erased,’’ and ‘‘interpreted’’ in ways that might contribute to
both stable and plastic neuronal properties (Figure 2). Of course
it is expected that many variations on this general theme exist
and that a multitude of interconnected molecular signaling path-
ways dictates the elaborate gene expression networks that
direct the complexities of nerve cell function.
Several broad questions can be posed at this juncture. Are
PTMs suited for on-off behavior of short-lived, binary switches
(Fischle et al., 2003) belonging to a different set from the PTMs
compatible with more lasting, graded responses? Are some
PTMs, or the protein complexes that engage them, more
compatible with short-term versus long-term memory, and is
there enough combinatorial readout of PTMs to deal with the962 Neuron 60, December 26, 2008 ª2008 Elsevier Inc.diversity and plasticity of neuronal cells? A wealth of histone
PTMs has been uncovered in a variety of cell models. Our goal
here was not to provide a compilation of them but to illustrate
general principles as they might apply to the nervous system,
by specifically highlighting distinct examples for further discus-
sion, including synaptic transmission, behavioral memory, drug
addiction, circadian rhythms, and mental retardation-autism
syndromes. Numerous reviews on chromatin biology (Berger,
2007; Lee and Workman, 2007), DNA methylation (Miranda
and Jones, 2007), and noncoding RNAs (Bernstein and Allis,
2005) have appeared in the literature (see Allis et al., 2007a, for
a textbook on epigenetics). Finally, a comprehensive nomencla-
ture has been proposed for chromatin-modifying enzymes (Allis
et al., 2007b).
Chromatin Remodeling: Defining Lasting States of Gene
Expression in the Nervous System
Chromatin contributes in ensuring that the storage, organization,
and readout of the genetic information occurs in a proper spatial
and temporal sequence during cellular differentiation and organ-
ismal development. The fundamental repeating unit of chro-
matin, the nucleosome core particle, consists of 147 bp of
DNA organized in approximately two superhelical turns of DNA
wrapped around an octamer of core histone proteins (two copies
each of H2A, H2B, H3, and H4 or variants thereof). When asso-
ciated with other components, higher-order nucleosomal struc-
tures are formed. Variations introduced into nucleosome array
structures by a variety of mechanisms (see below) cause subtle,
but meaningful, differences in chromatin compaction that corre-
late closely with more ‘‘open’’ versus ‘‘closed’’ states. These
states loosely correlate with ‘‘euchromatin’’ versus ‘‘heterochro-
matin’’ states that often, but not always, align with ‘‘active’’
versus ‘‘inactive’’ states of gene expression, respectively
(Berger, 2007). Covalent histone modifications, histone variants,
or chromatin remodeling complexes work together to alter the
chromatin fiber (Cheung et al., 2000a; Strahl and Allis, 2000).
For example, histone acetylation, a charge-altering modification
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has long been correlated with transcriptional activation (Cheung
et al., 2000a), likely due to weakening of histone:DNA contacts.
In contrast, histone hypoacetylation correlates closely with
gene silencing (Lee and Workman, 2007).
For the purposes of this review, several well-studied PTMs
serve to illustrate paradigms emerging in present-day chromatin
biology, with neurobiologists only beginning to consider how
these modifications contribute to neuronal functions (Crosio
et al., 2003; Levenson and Sweatt, 2005; Tsankova et al.,
2007). For example, acetylation and methylation result from the
addition or removal of acetyl and methyl or groups enzymatically
donated from respective high-energy donors (acetyl coenzymeA
[acetyl-CoA] and S-adenosyl methionine [SAM]; see Table 1).
Histones are acetylated by histone acetyltransferases (HATs),
which comprise a large family of enzymes, and deacetylated
by histone deacetylases (HDACs), which are divided in different
families. Class I HDACs are believed to provide the major HDAC
catalytic activity present in brain, which is then modified by
class II HDACs through direct binding interactions. Class III
HDACs represent a distinct subfamily, as discussed under circa-
dian regulation below. Both histone H3 and H4 undergo polyace-
tylation at nearby lysine residues in the proteins’ N termini;
however, still much more needs to be uncovered about the tar-
geted recruiting and specificity of individual HATs and HDACs
involved in these reactions.
Figure 2. Distinct Classes of Chromatin Remodeling Molecules
Specific marks on the N-terminal tails of core histones are PTMs elicited by
chromatin remodeling machineries that include a large variety of regulatory
molecules, many of which interact physically and functionally. Conceptually,
the regulators may be indicated as follows. (1) Writers. These are enzymes
such as kinases, HATs, and HMTs that modify specific substrates adding
phosphate, acetyl, or methyl groups. (2) Readers. These include a large variety
of regulatory proteins that share unique domains implicated in recognizing
acetyl or methyl groups. Some other domains, such as BRCT (Manke et al.,
2003) and a specific region in 14-3-3 (Macdonald et al., 2005), can be consid-
ered as readers of phosphate. Often, ‘‘readers’’ recruit to chromatin additional
epigenetic effectors. (3) Erasers. These enzymes include phosphatases,
HDACs, and DMTs, which directly remove PTMs.Methylation affects DNA, RNA, and histone and nonhistone
proteins, at least to varying degrees in different organisms. In
some cases, intriguing links have emerged between histone
modifications, and specifically methylation, and DNA methyla-
tion (Mutskov et al., 2002; Ooi et al., 2007). Second, within any
potential histone or nonhistone protein that is methylated,
multiple lysines or arginines can be modified, often existing
together in localized regions of the same or different histone
domains. Thus, at least for lysine- and arginine-rich proteins
like histones, a wealth of biological readouts may be possible.
Third, and expanding on the complexity of methylation, indi-
vidual lysine residues can be mono-, di-, or trimethylated; simi-
larly, arginine residues can be mono- or dimethylated, and these
can be dimethylated in a symmetric or asymmetric fashion.
These various methylation reactions are mediated by distinct
subtypes of histone methyltransferases and demethylases, as
discussed in the next section. Note that, unlike acetylation,
methylation does not alter the positive charge of the targeted
lysine or arginine, suggesting potential differences in regulatory
outputs. Fourth, methylation of distinct lysine residues has oppo-
site functional consequences on gene activation (see below).
Fifth, all of the core histones (Shi and Whetstine, 2007) are meth-
ylated depending upon the physiological setting. Moreover, in
keeping with studies on acetylation, methylation is not limited
to histone proteins. Nonhistone proteins, such as the tumor
suppressor p53 (Huang et al., 2007; Shi et al., 2007), are physio-
logical targets of methylation reactions, a growing list likely to
cross over into neuronal-specific proteins. Thus, methylation
alone provides a remarkable number of regulatory options to
the cell (Ruthenburg et al., 2007a). Combining methylation with
other PTMs, such as acetylation, causes a remarkable array of
possibilities. As discussed in the next paragraph, we favor
a scenario where the controlled addition and removal of specific
PTMs results into unique combinations that constitute a sort of
‘‘epigenetic indexing code’’ that corresponds to distinct physio-
logical states and genomic functions.
Decoding the ‘‘Epigenetic Indexing Code’’: Writing,
Reading, and Erasing Key Marks
Remarkable progress has been made in characterizing what is
often being referred to as ‘‘writers, readers, and erasers’’ of
PTMs in histone and nonhistone proteins (Figure 2). Thus,
Table 1. Linking Histone Modifications to Metabolism
Phosphorylation ATP/ADP
Methylation SAM/SAH, FAD/FADH2
Acetylation Acetyl-CoA/CoA, NAD/NADH,
Acetyl-ADP-ribose
Ubiquitylation/sumoylation glucose?
Glycosylation UDP-GlcNAc/UDP
Posttranslational modifications are elicited by specific enzymes whose
activity depends on the intracellular levels of essential metabolites, thus
sensing cellular metabolism, nutrients, and energy levels in the cell.
PTMs target specific sites on histones, indicating that transient states
of chromatin remodeling are under dynamic regulation of cellular
physiology.Neuron 60, December 26, 2008 ª2008 Elsevier Inc. 963
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global distribution (or ‘‘patterns’’) of histone PTMs using a variety
of high-resolution genomic profiling methods (Bernstein et al.,
2005; Barski et al., 2007). It emerges from these studies that ‘‘ep-
igenomes’’ are highly organized and strikingly nonrandom with
respect to histone and DNA modifications (reviewed in Bernstein
et al., 2007). Evidence discussed in this review indicates that the
enzymatic machinery that elicits these PTMs operates under the
control of a variety of neuronal stimuli, which link physiological
variations to modulated chromatin remodeling and thereby
controlled gene expression (Figure 3). One important consider-
ation relates to the intracellular pathways involved in the marking
of these PTMs. Interestingly, all use physiological metabolites,
thereby indicating that the dynamic process of chromatin re-
modeling may ‘‘sense’’ cellular metabolism and changes in
energy levels (Table 1), which are highly controlled and function-
ally essential in neuronal responses.
Selected combinations of numerous PTMs occur at specific
residues of the histone H3 N-terminal tail (Figure 3). For example,
high levels of H3 and H4 acetylation and H3 lysine 4 methylation
(H3K4me) are generally present in promoter regions of active
genes (Ruthenburg et al., 2007b). In contrast, elevated levels of
H3 lysine 27 (H3K27me) correlate with gene repression mediated
by the protein Polycomb (Trojer and Reinberg, 2006). Interest-
ingly, the ‘‘degree’’ of histone lysine methylation matters, with
significant differences in large-scale patterns of mono-, di-,
and trimethylation at specific lysine residues, whether activating
or repressing (Barski et al., 2007). These sorts of epigenetic
indexing patterns vary in different cell types or during different
stages of development (Marin-Husstege et al., 2002; Lessard
et al., 2007; Putignano et al., 2007). For example, a ‘‘bivalent
domain,’’ characterized by a configuration of marking genes
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Figure 3. Multiple Posttranslational
Modifications on Histone Tails
The H3 N-terminal tail, here presented as a para-
digm of all histone tails, can undergo numerous
modifications. Here, only phosphorylation, acety-
lation, and methylation are indicated. Methylation
can be mono-, di-, or trimethyl. The enzymatic
machinery that elicits these PTMs is believed to
be under the physiological control of neuronal
stimuli. Specific combinations of PTMs corre-
spond to selective states of chromatin, either
permissive or not for transcription, responsive to
damage and stress, or modulated by physiological
changes in cellular metabolism.
with both ‘‘ON’’ (H3K4me) and ‘‘OFF’’
(H3K27me), was noted in key develop-
mental genes in embryonic stem cells
(Bernstein et al., 2006). How bivalent
domains are resolved during develop-
ment is not known. As well, the extent
to which neuronal cells use the strategies
of histone PTMs as part of a mechanism
for establishing ‘‘epigenomes’’ under-
lying neuronal diversity is not clear. How
does DNA methylation and noncoding
RNA enter into the above equation?
Recent findings suggest that all of these components work
together to bring about a ‘‘language’’ that greatly exceeds that
of DNA alone (Ooi and Henikoff, 2007).
If histone methylation does not alter the charge of target
lysines or arginines, how does histone methylation function?
Unlike acetylation, where charge-based mechanisms are likely
to apply, histone:DNA contacts might not be affected by histone
methylation in what can be referred to as ‘‘cis’’ (structural) effects
on nucleosome structure. Likely, histone methylation is ‘‘read’’
by effector proteins that bring about meaningful downstream
events by ‘‘trans’’ mechanisms (Figure 2). Effector proteins
contain ‘‘reader’’ modules that structural and functional
evidence identify as relatively short (50–100 aa) binding motifs,
such as chromodomains or PHD fingers, which read histone
methyl-lysine marks with remarkable and elegant precision
(Ruthenburg et al., 2007a; Lee and Workman, 2007). Similarly,
as suggested in early articulations of the histone and epigenetic
code hypotheses (Cheung et al., 2000a; Strahl and Allis, 2000;
Jenuwein and Allis, 2001; Turner, 2002), specific acetyl-lysine
marks are also read in histone and nonhistone proteins by bro-
modomains. Also, interplays exist between adjacent or neigh-
boring modifications that may serve to govern the binding and
interactions of the effector proteins (Fischle et al., 2003). Under-
standing the extent to which such repeated modules read PTMs,
either on a single histone tail or on multiple tails or even distinct
nucleosomes, remains a challenge for future studies.
The general stability of DNA and histone methylation marks, as
compared to rapid turnover kinetics PTMs such as acetylation
and phosphorylation (Figure 4), prompted early speculation
that methylation might be the ideal epigenetic indexing system
(Jenuwein and Allis, 2001; Bannister and Kouzarides, 2005).
While the situation with DNA demethylation remains unclear,964 Neuron 60, December 26, 2008 ª2008 Elsevier Inc.
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(Fan et al., 2001; Miller and Sweatt, 2007), progress has been
made in the area of histone demethylation. Demethylase activi-
ties are being described for essentially all of the well-known
lysine methyl sites in histones, not to mention those that are
selective for mono-, di-, or trimethylation states (Trojer and Rein-
berg, 2006), promising to carry this family of enzymes into the
‘‘celebrity status’’ of other chromatin modifiers, such as HATs
and HDACs. Recent findings indicate that some of these
enzymes turn out to be critical in neuronal functions. For
example, the histone H3K4 tridemethylase SMCX links repres-
sion of target genes (e.g., the sodium channel type 2A and syn-
apsin 1) to mental retardation and epilepsy (Tahiliani et al., 2007).
These studies underscore several important points. First, they
point to a general model wherein failure to remove, or most
certainly add, ‘‘ON’’ epigenetic marks, such as H3K4me3 (or
likely ‘‘OFF’’ marks as well), impairs downstream neuronal
gene regulation leading to disease states by yet undefined
mechanisms. Second, disease phenotypes are not always asso-
ciated with alterations in enzyme activity. For example,
H3K4me3 demethylase activity was examined in a small series
of SMCX mutations, which interestingly correlated roughly with
the severity of mental retardation in human patients affected
with these mutations. In some cases, the mutations studied
affected enzymatic activity, while in other cases the mutations
affected the intracellular location of the protein or its association
with other SMCX complex components. Third, SMCX contains
multiple modules, including two PHD fingers, suggestive of
a yet unknown methylation ‘‘reading’’ function. Stabilization of
the protein in the remodeling complexes within the chromatin
template may occur in part through this type of binding module
(Wysocka et al., 2006; Taverna et al., 2006; Li et al., 2007). Inter-
estingly, several of the mutations in the mental retardation-asso-
ciated SMCX demethylase fall within some of its reading
modules (Jensen et al., 2005). Similarly, the intriguing interaction
between ATRX, a DNA helicase/ATPase mutated in the ATRX
syndrome (a-thalassemia/mental retardation, X-linked) and
MeCP2, a regulator of DNA methylation causally linked to Rett’s
syndrome (see later), is disrupted by mutations responsible for
the pathologies associated with these two epigenetic regulators
(Nan et al., 2007). As a footnote, we point out that many chro-
matin remodeling activities and histone-modifying enzymes
contain one or more modules, such as bromodomains, chromo-
domains, and PHD fingers, linked in various combinations (Lee
and Workman, 2007). Thus, while it is convenient to discuss
‘‘writers’’ and ‘‘readers’’ of PTMs separately (Figure 1), many
writers and erasers contain their own reading modules whose
functions remain unclear (Figure 2). In mixed lineage leukemia
(MLL), for example, the writer of H3K4 methyl marks (Ruthenburg
et al., 2007a) contains a series of PHD fingers and an atypical
bromodomain whose function is unknown. We predict that deci-
phering the ‘‘epigenetic indexing code’’ will help reveal the path-
ways responsible for the timing, intensity, and precision of
‘‘memorized’’ gene expression.
This evolving knowledge of chromatin remodeling mecha-
nisms has already begun to inform our understanding of the
regulation of brain function under normal conditions and certain
pathophysiological states, as will be seen in the sections that
follow.
Does Chromatin Remodeling Influence
Synaptic Plasticity?
Repeated patterns of synaptic transmission lead to diverse
forms of synaptic plasticity at excitatory and inhibitory synapses,
e.g., long-term potentiation (LTP) or long-term depression (LTD),
whereby the efficacy of synaptic transmission is up- or downre-
gulated, respectively. Certain forms of LTP and LTD are long
lived and thought to be dependent on lasting changes in gene
expression. Based on the critical role that chromatin remodeling
plays in dictating a transcription-permissive or silencing state of
the genome (Felsenfeld and Groudine, 2003), it is notable that
growing evidence suggests that histone PTMs may be involved
in these processes. For example, H4 acetylation at specific
promoters in Aplysia is altered after LTP and LTD (Guan et al.,
2002), and HDAC inhibitors promote LTP in mammalian neurons
(Levenson et al., 2004). Additionally, during synaptic transmis-
sion, neurotransmitters trigger responses in target neurons by
activating two major families of receptors, ligand-gated ion
channels and G protein-coupled receptors. Likewise, growth
factors and cytokines are released from neurons in an activity-
dependent manner and act on target neurons through
receptor-mediated signaling. Triggering signaling cascades in
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Figure 4. Dynamic Changes in Histone Modifications
in the Hippocampus
Chromatin remodeling occurs in hippocampal neurons of the dentate gyrus
30 min after administering kainic acid (35 mg/kg) to a mouse. Kainate recep-
tors are involved in epileptogenesis and synaptic plasticity. H3S10 phosphor-
ylation in these neurons is induced by stimulation of dopamine, acetylcholine,
and glutamate receptors and is often associated with acetylation at H3K14
(Crosio et al., 2003). These events are coupled to transcriptional activation in
hippocampal neurons. An antibody that recognizes specifically H3 P-S10
was used.Neuron 60, December 26, 2008 ª2008 Elsevier Inc. 965
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changes in gene expression via control of transcription and
thereby chromatin remodeling (Figures 3 and 4).
One paradigmatic example involves the transcription factor
CREB, which, once activated by signaling-induced phosphoryla-
tion, recruits CREB-binding protein (CBP), a coactivator with
intrinsic HAT activity (Lonze and Ginty, 2002). In addition, an
increase in cellular Ca2+ levels in muscle activates Ca2+/calmod-
ulin-dependent kinases, which phosphorylate class II HDACs.
This phosphorylation provides a docking site for the ‘‘reader’’
protein 14-3-3, which mediates the export of the phosphorylated
HDACs from the nucleus (McKinsey et al., 2000). This pathway
operates in hippocampal, striatal, and cerebellar granule
neurons (Chawla et al., 2003; Renthal et al., 2007) and could
represent a widespread mechanism of Ca2+-mediated histone
acetylation and gene expression.
Independent of histone deacetylation, class II HDACs can
recruit cyclin-dependent kinase-5 (Cdk5) to phosphorylate myo-
cyte enhancing factor 2 (MEF2), a protein that mediates activity-
dependent changes in synapse formation in neurons, and
repress its transcriptional activity (Gong et al., 2003; Pulippara-
charuvil et al., 2008). These studies reveal mechanisms by which
synaptic activity may mediate long-lasting changes in brain,
such as those associated with drug addiction. As discussed
later, intriguing similarities indicate that some common pathways
of epigenetic control may be relevant to memory and neurode-
generative disease.
Synaptic activity is also reported to influence DNA methyla-
tion. This is unexpected, as it suggests that DNA methylation,
classically thought as a very stable modification, undergoes
rapid and dynamic regulation in the nervous system (Levenson
et al., 2006). An important example is the activity-dependent
control of Bdnf gene expression that has been correlated with
reduced DNA methylation and release of a repressor complex
comprising methyl-CpG binding protein (MeCP2; a protein that
binds to and represses methylated DNA; Chen et al., 2003; Mar-
tinowich et al., 2003; Chang et al., 2006). It is proposed that
neural activity, via increases in cellular Ca2+ levels and activation
of Ca2+/calmodulin kinases, leads to the phosphorylation of
MeCP2 and its release from the Bdnf promoter. This induces
Bdnf expression and attendant dendritic outgrowth (Chen
et al., 2003).
In addition to direct mediators of these synaptic changes,
various immediate-early genes seem to be particular targets of
synaptic-plasticity-regulated epigenetic control. For example,
the induction of c-fos is associated with dramatic increases in
H4 acetylation and H3 phospho-acetylation (Figure 4; Crosio
et al., 2003; Li et al., 2004; Brami-Cherrier et al., 2005; Kumar
et al., 2005). Perturbation of dopamine signaling triggers the
dramatic induction of c-fos and other immediate-early genes in
distinct subsets of striatal neurons in response to psychostimu-
lant drugs of abuse (e.g., cocaine and amphetamine) and in
response to antipsychotic drugs that block D2 dopamine recep-
tors (Welter et al., 2007). The nuclear accumulation of DARPP32,
a protein phosphatase 1 inhibitor, has been recently invoked in
cocaine-induced H3 S-10 phosphorylation (Stipanovich et al.,
2008). Another study implicated mitogen and stress activated
kinase 1 (MSK1) in cocaine stimulation of H3 P-S10 and c-fos966 Neuron 60, December 26, 2008 ª2008 Elsevier Inc.induction (Brami-Cherrier et al., 2005), although other kinases
may be also implicated in response to various stimuli (Sas-
sone-Corsi et al., 1999; Nowak and Corces, 2004). Likewise,
induction of c-fos by seizure activity or memory paradigms in
other brain regions such as hippocampus is associated with
H3 phosphoacetylation and ERKs (extracellular signal regulated
kinases) activation (Crosio et al., 2003; Tsankova et al., 2004;
Levenson and Sweatt, 2005; Chwang et al., 2006). Several other
kinases can phosphorylate H3 S10 in nonneuronal cells, but their
actions in brain are unexplored.
Histone Modifications Affect Behavioral Memory
Consistent with the coupling of histone modifications with
synaptic plasticity and correlations between behavioral plasticity
and epigenetic control of immediate-early gene transcription,
there are numerous reports of the importance of histone modifi-
cations in behavioral memory. Mice deficient in CBP exhibit
memory deficits, and administration of an HDAC inhibitor can
restore normal long-term memory formation in the mutants,
and even enhance it in normal animals (Alarcon et al., 2004; Kor-
zus et al., 2004; Levenson et al., 2004). Contextual fear condi-
tioning, or activation of the ERK pathway that is thought to
contribute to memory formation, increases levels of H3S10-
K14 phospho-acetylation in the CA1 area of hippocampus,
without affecting H4 acetylation (Levenson and Sweatt, 2005;
Chwang et al., 2006). Interestingly, changes in histone acetyla-
tion and methylation in hippocampus have also been implicated
in depression and antidepressant action, where HDAC inhibitors
exert antidepressant-like effects (Tsankova et al., 2006;
Schroeder et al., 2007).
Recent work has implicated changes in DNA methylation in
learning and memory as well. Contextual fear conditioning
induces the expression of Dnmt3A and -3B in CA1 of hippo-
campus, and administration of the DNMT inhibitors, zebularine
and 5-aza-2-deoxycytidine, blocks the induction of both contex-
tual fear conditioning (Miller and Sweatt, 2007) and hippocampal
LTP (Levenson et al., 2006). However, it remains unknown how
these drugs, which are thought to regulate DNA methylation in
dividing cells only, affect gene expression in mature neurons.
Fear conditioning causes rapid methylation and silencing of the
protein phosphatase 1 (Pp1) gene promoter (Miller and Sweatt,
2007), a gene important for LTP and memory formation. Interest-
ingly, fear conditioning also induces demethylation of the Reelin
promoter (Dong et al., 2007), indicating that both DNA methyla-
tion and demethylation may be highly regulated in the adult brain.
Chromatin Remodeling Mechanisms in Drug-Induced
Plasticity and Addiction
Drug addiction can be viewed as a form of drug-induced neural
plasticity, whereby repeated exposure to drugs of abuse leads to
long-lasting changes in the brain’s natural reward centers and
associated memory circuits, which underlie the addiction pheno-
type (Hyman et al., 2006). One major site for these lasting
changes is the nucleus accumbens (NAc)—the ventral portion
of the striatum, although many other regions are also involved.
Drug-induced changes in gene expression, largely driven by
dopaminergic signaling, occur in the NAc and other relevant
regions (Tsankova et al., 2007). Some of these changes persist
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with the persisting behavioral abnormalities. These observations
have driven research into chromatin remodeling as one molec-
ular basis of sustained, even life-long, alterations in gene expres-
sion in brain reward regions that underlie an addicted state
(Tsankova et al., 2007).
As stated earlier, an acute dose of cocaine induces the
expression of fos family immediate-early genes in the NAc and
dorsal striatum, an event associated with a rapid and transient
increase in H4K5 acetylation (Brami-Cherrier et al., 2005; Kumar
et al., 2005). CBP, with its intrinsic HAT activity, has been impli-
cated in these effects (Levine et al., 2005). Acute cocaine also
induces Ser10/Lys14 H3 phospho-acetylation at the c-fos
promoter (Crosio et al., 2003; Kumar et al., 2005), an event that
is mediated by activation of ERKs and could require the protein
kinase MSK1 (Lu et al., 2006; Brami-Cherrier et al., 2005). In
contrast, chronic exposure to cocaine activates or represses
many distinct genes compared to acute treatment. The c-fos
gene, for instance, desensitizes in the NAc during a course of
chronic drug exposure, while the fosB gene continues to be
induced, and these changes are associated with decreased
and increased histone acetylation at these genes, respectively.
In addition, chronic cocaine increases H3K9 methylation at the
c-fos gene, a modification tightly associated with gene repres-
sion. This effect could be mediated by the induction in the NAc
of SUV39H1, a Lys9 histone methyltransferase (Renthal et al.,
2008). Interestingly, several genes that are selectively induced
in the chronic state, such as Cdk5 and Bdnf (Bibb et al., 2001;
Grimm et al., 2003), are associated with increased H3 acetyla-
tion. Cocaine induction of H3 acetylation at the Bdnf promoter
builds over a week of withdrawal (Kumar et al., 2005), and this
change precedes the progressive increase in Bdnf expression
in this brain region (Grimm et al., 2003). Little is known about
the specific HATs and HDACs that may mediate these changes
in histone acetylation at cocaine-regulated genes. Yet these
results highlight the importance of exploring genome-wide chro-
matin alterations, by use of ChIP on chip (Lee et al., 2003) or
SACO (Impey et al., 2004) or related techniques, to identify
many other genes whose dysregulation contributes to cocaine
addiction. Genome-wide epigenetic approaches have yielded
exciting results in the fields of developmental (Lessard et al.,
2007) and cancer biology (Lee et al., 2003).
The transcription factor DFosB is implicated in the transition to
an addicted state in chronic drug treatment (Nestler, 2008).
DFosB is a truncated product of the fosB gene, which accumu-
lates uniquely during chronic drug treatment due to its unique
protein stability (Ulery et al., 2006). Gene expression array exper-
iments indicate that DFosB accounts for >25% of all changes in
steady-state mRNA levels induced in the NAc by chronic cocaine
administration (McClung and Nestler, 2003). ChIP assays have
shown that the induction by cocaine of one of these mRNAs,
Cdk5, represents a direct, activating effect of DFosB on the
Cdk5 gene (Kumar et al., 2005). By contrast, Bdnf is not a direct
target of DFosB, consistent with a different mechanism being
involved in its induction (McClung and Nestler, 2003). Induction
of Cdk5, in turn, partly mediates the effects of chronic cocaine
and of DFosB on dendritic remodeling in the NAc (Norrholm
et al., 2003; Lee et al., 2006). DFosB is also responsible forc-fos repression after chronic cocaine, where it recruits
HDAC1, leading to the deacetylation of nearby histones (Renthal
et al., 2008). These findings support a model in which the accu-
mulating DFosB interacts with distinct chromatin remodeling
factors at specific promoters of genes that control reward
neurons in this brain region.
Cocaine-induced chromatin remodeling is mediated in part via
regulation of the enzymatic machineries that control histone
acetylation and methylation. For example, phosphorylation of
HDAC5, a class II HDAC enriched in the NAc, is induced by
chronic cocaine exposure (Renthal et al., 2007), consistent
with activation of Ca2+/calmodulin-dependent kinases in this
brain region (Mattson et al., 2005). Another example is the tran-
scriptional regulator nucleus accumbens 1 (NAC-1), which is
highly induced by cocaine in the NAc and interacts with
HDAC3 and HDAC4 (Korutla et al., 2005). Chronic cocaine also
induces the HMT SUV39H1 in the NAc (Renthal et al., 2008).
Drug-induced chromatin remodeling is behaviorally relevant.
Systemic or intra-NAc administration of HDAC inhibitors, or
knockout of HDAC5, potentiates behavioral responses to
cocaine, whereas viral-mediated overexpression of HDAC5
specifically in the NAc has the opposite effect (Kumar et al.,
2005; Renthal et al., 2007). Interestingly, overexpression of
HDAC4, but not HDAC9, has a similar effect, suggesting some
specificity of HDAC action, the basis of which is still poorly
understood. Moreover, CBP-deficient mice show reduced
cocaine-induced locomotor activity (Levine et al., 2005).
There are also several reports of chromatin changes after
chronic ethanol administration (Mahadev and Vemuri, 1998;
Bonsch et al., 2006; Bardag-Gorce et al., 2007). Interestingly,
maternal ethanol consumption has been associated with lasting
changes in DNA methylation in the fetal heart, which may
contribute to increased risk of ischemic injury (Zhang et al.,
2007). Identification of chromatin changes in blood and other
peripheral tissues as a consequence of chronic ethanol adminis-
tration raises the possibility of using such epigenetic markers to
monitor drug use in vulnerable human populations.
Intriguing connections have also been found between dopa-
mine neurotransmission and the circadian clock machinery, via
D2 receptors (Yujnovsky et al., 2006; Doi et al., 2006b; Yan
et al., 2006). Dopamine is the major catecholamine in retinal
neurons and plays a central role in neural adaptation to light (Iu-
vone et al., 1978), mostly through D2 receptors highly expressed
in these neurons (Doi et al., 2006b). Light stimulates the
synthesis, turnover, and release of retinal dopamine, and dopa-
minergic activity is higher during the day than at night. Thereby,
dopamine is a likely mediator of light signaling to the retinal circa-
dian clock. Activation of D2 receptors stimulates CLOCK:BMAL1
function through the MAPK signaling pathway. Since CLOCK is
a HAT (see the next section; Doi et al., 2006a), dopamine may
exert its function by signaling directly to the HAT potential of
CLOCK (Figure 5). Another tempting speculation includes the
involvement of the AKT/GSK-3 transduction pathway, which is
implicated in D2 receptor-dependent signaling (Beaulieu et al.,
2007). GSK-3 kinase function is tightly regulated by lithium, an
antimanic and antidepressant agent (Beaulieu et al., 2008), and
shaggy, the GSK-3 Drosophila homolog, plays an essential role
in circadian control (Martinek et al., 2001). Thus, this regulatoryNeuron 60, December 26, 2008 ª2008 Elsevier Inc. 967
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chromatin remodeling.
The Circadian Clock: How to ‘‘Time’’ Periodic
Chromatin Remodeling
Unlike memory and addiction behaviors, the neuronal dynamic
response that underlies circadian regulation is peculiar, as it is
characterized by an oscillatory and recurrent pattern of gene
expression. About 15,000 neurons within the hypothalamic
suprachiasmatic nucleus (SCN) constitute the mammalian
master pacemaker, a highly organized structure that synchro-
nizes peripheral oscillators to ensure temporally coordinated
physiology (Saper et al., 2005). In SCN neurons, a number of
clock genes display the unique pattern of oscillatory gene
expression that respects a rhythm of about 24 hr (Dunlap,
1999). Similarly, almost all peripheral cells in the organism
show circadian rhythmicity and oscillatory expression of clock-
controlled genes. Remarkably, at least 10% of all mammalian
transcripts oscillate with circadian rhythmicity (Panda et al.,
2002), revealing that a highly efficient molecular machinery
must thereby operate to insure periodic chromatin remodeling.
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Figure 5. Signaling Pathways Linking Dopamine to the Circadian
Clock
Dopamine controls many brain functions, including roles in behavior and
cognition, motor activity, motivation, and reward. Signaling mediated by D2
receptor is envisaged to control chromatin remodeling via modulation of
various enzymatic functions. By using either the ERK transduction pathway
or the alternative AKT/GSK-3 signaling system, dopamine could control
kinases that phosphorylate H3, such as Rsk2 and MSK1, or the enzymatic
function of HATs, such as CBP or CLOCK. The GSK-3 kinase is inhibited by
lithium and thereby is implicated in the treatment of mood disorders. These
regulatory pathways may integrate circadian control, dopamine signaling,
and chromatin remodeling.968 Neuron 60, December 26, 2008 ª2008 Elsevier Inc.Several studies have described that histone modifications occur
at promoters of clock-controlled genes and that these—specifi-
cally acetylation—show a rhythmic pattern (Etchegaray et al.,
2003; Naruse et al., 2004; Ripperger and Schibler, 2006). These
correlative analyses indicated that transcription-permissive
chromatin states are dynamically established in a circadian-
time-specific manner but did not demonstrate whether unique
chromatin remodeling events are required for clock control,
i.e., cause versus effect. Additional studies indicated that
H3K27 methylation also oscillates at mammalian clock gene
promoters (Etchegaray et al., 2006), whereas ATP-dependent
chromatin remodeling operates within the circadian machinery,
at least in Neurospora (Belden et al., 2007). This collection of
reports underscored the complexity of the circadian machinery,
which is constituted in large part of a variety of transcription
factors whose structural features have been analyzed during
the past 10 years. The finding that a master clock regulator, the
protein CLOCK, is an enzyme with HAT activity provided the key
to unlock the regulatory code that causally couples circadian
chromatin plasticity and transcription (Doi et al., 2006a).
CLOCK shares a number of structural features with ACTR,
a HAT previously shown to function as a coactivator for some
nuclear receptors (Doi et al., 2006a). In addition to the carboxyl-
terminal glutamine-rich region—the domain where the HAT func-
tion resides—similarities include the highly conserved bHLH-
PAS domain at the N13 termini, a nuclear receptor interaction
domain (NRID), as well as serine-rich regions within the middle
portion of both proteins. Yet, some features show that CLOCK
is a unique HAT. Indeed, while the overall organization resembles
the SRC-type of HAT, the acetyl-coenzyme A (CoA) binding motif
is more similar to the MYST-family of HAT proteins, a combination
not found in other HATs. In addition, when dimerized with its
partner BMAL1, CLOCK binds DNA at E box promoter elements
of clock-controlled genes, thereby functioning as a classical
bHLH type of transcription factor.
CLOCK acetylates histones H3 and H4, with specific prefer-
ence for H3K14 (Doi et al., 2006a), an event associated with tran-
scriptional activation. Acetylation at K14 is enhanced by prior
phosphorylation at Ser10 in fibroblasts (Cheung et al., 2000b;
Lo et al., 2000). Importantly, light-induces phosphorylation at
H3S10 in SCN’s neurons (Crosio et al., 2000), indicating that
light-mediated signaling influences the state of higher chromatin
organization and suggesting that coordinated PTMs of histones
may contribute to the integration of light signaling and clock
function (Figure 2).
As other HATs (Sterner and Berger, 2000), CLOCK also acet-
ylates nonhistone proteins. CLOCK acetylates its own partner,
BMAL1, at position Lys537, an event that is regulated in
a rhythmic manner and that is critical for circadian control (Hir-
ayama et al., 2007). This finding suggests that CLOCK may
have several putative targets and that their identification is likely
to provide significant clues about the neuronal pathways influ-
enced by the circadian clock. In this respect, another protein
may play a relevant regulatory function: NPAS2. This is an alter-
native partner of BMAL1, whose structure is loosely similar to
CLOCK (Reick et al., 2001). Interestingly, NPAS2 displays
a neuronal-specific distribution, being abundant in the forebrain
areas, including the cortex, hippocampus, striatum, amygdala,
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sleep and behavioral adaptability (Dudley et al., 2003). While it is
yet unclear whether NPAS2 may have acetyltransferase activity,
its dimerization with BMAL1 confers to it a potential role in indi-
rectly regulating CLOCK’s HAT activity.
Interestingly, CLOCK expression is not rhythmic (Gekakis
et al., 1998), whereas CLOCK’s enzymatic function is, indicating
that its chromatin remodeling activity is critical for circadian
physiology (Doi et al., 2006a). The finding of a circadian HAT
opened the search for a counterbalancing HDAC. Recent reports
indicate that SIRT1 may play this role (see Nakahata et al., 2008;
and Figure 3). SIRT1 belongs to the family of sirtuins that consti-
tutes the so-called class III of HDACs. These are the only HDACs
whose enzymatic activity is NAD+ dependent and that has been
intimately linked to the control of metabolism and aging (Bishop
and Guarente, 2007). SIRT1 directly associates with CLOCK and
functions as a rheostat in modulating the acetylation state of
histone H3 and BMAL1 (Nakahata et al., 2008). These results
are relevant in establishing a direct molecular coupling between
circadian control and energy metabolism (Figure 6). The CLOCK-
SIRT1 complex is in fact regulated by the NAD+/nicotinamide
balance in the cell (Nakahata et al., 2008; Asher et al., 2008),
providing a novel perspective to the links between circadian
rhythms, metabolism, and cellular reduction-oxidation pathways
(Wijnen and Young, 2006). Intriguingly, SIRT1 has been found to
regulate aging and neurodegeneration (Gan and Mucke, 2008).
For example, inhibitors of SIRT1 rescue a-synuclein-mediated
toxicity in animal models of Parkinson’s disease (Outeiro et al.,
2007). As the role of dopamine in neurotoxicity and neuroprotec-
tion is established (Bozzi and Borrelli, 2006), this may represent
an intriguing link between dopamine signaling and SIRT1-medi-
ated metabolic control in neurons. Indeed, SIRT1 has also been
found to contribute to the redox-dependent fate of neural
progenitors (Prozorovski et al., 2008).
Getting ‘‘Nervous’’ about Chromatin Remodeling:
Disease Links
Given the involvement of epigenetic mechanisms in nervous
system function, it is not surprising that a growing number of
disorders, in particular mental retardation and autism spectrum
syndromes, have been linked to chromatin remodeling defects.
This likely relates to the elegant control pathways that exist to
regulate activation of neuronal gene programs as well as repres-
sion of nonneuronal gene sets in neuronal tissues (Feng et al.,
2007). Well-studied, for example, is the REST/coREST repressor
complex that serves to silence numerous neuronal genes in non-
neuronal cells (Ballas and Mandel, 2005). Interestingly, REST/
coREST contains HDACs and other chromatin regulators often
associated with gene silencing. Thus, a neuronal differentiation
program, from stem or progenitor cell to a well-connected post-
mitotic neuron, requires ‘‘undoing’’ the above-mentioned epige-
netic silencing program. Taking clues from other well-studied
‘‘ying-yang’’ chromatin relationships (Ruthenburg et al., 2007a),
it seems likely that reversal of silencing includes hyperacetyla-
tion of the H3 and H4 N tails along with hypermethylation of
H3K4. Interestingly, the finding that HATs (such as MOF, for mal-
ess on the first) and HMTs (for histone methyltransferases such
as MLL) coexist in large complexes suggests that this machineryoperates to bring about concerted gene-activating reactions
(Dou et al., 2006; Taverna et al., 2006; Li et al., 2007). The
H3K4 tridemethylase complex SMCX (Tahiliani et al., 2007), for
example, contains the repressive HMT G9a, a writer of repres-
sive H3K9me marks, and a H3K9me reader known as HP1a˜,
a heterochromatin-associated protein, which uses its chromo-
domain module to ‘‘dock’’ onto H3K9me marks. These findings
are paralleled by previous observations on the concerted func-
tion of kinases and HATs (Lo et al., 2001; Merienne et al.,
2001) and of interdependent trans-modifications on distinct
histone tails (Sun and Allis, 2002).
How might disruption of the concerted action of chromatin
modifiers translate into pathological conditions? Some impor-
tant examples exist (Ausio et al., 2003; Levenson and Sweatt,
2005; Tsankova et al., 2007). The most well-studied ‘‘epigenetic
disease’’ associated with altered neurological function, is Rett’s
syndrome, an X-linked postnatal autism spectrum disorder char-
acterized by stereotypical motor, learning, and social abnormal-
ities that generally worsen over time (Moretti and Zoghbi, 2006).
Candidate gene analyses identified MeCP2 as the causative
gene (Amir et al., 1999). MeCP2 was identified on the basis of
binding selectively to methylated CpG dinucleotides in hetero-
chromatic regions and functioning in a methylation-dependent
repressive fashion (Nan et al., 1997). Thus, MeCP2 can be
described as a DNA ‘‘reader’’ in analogy to readers of histone
methylation (Figure 2). In keeping with the general theme devel-
oped above for REST/coREST and SXMC repressive
complexes, engagement with additional corepressors and
HDACs provide the enzymatic ‘‘punch’’ to the silencing activity
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Figure 6. CLOCK-Mediated Acetylation and Regulation by SIRT1,
an NAD+-Dependent HDAC
CLOCK acetylates H3 and its dimerization partner BMAL1 to regulate clock-
controlled genes. SIRT1 associates with CLOCK and, in response to metabolic
changes in intracellular NAD+ levels, modulates clock-controlled genes by
virtue of its HDAC enzymatic activity. Thus, metabolic, nutritional, and environ-
mental cues modulate the circadian machinery via chromatin remodeling.Neuron 60, December 26, 2008 ª2008 Elsevier Inc. 969
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and thereby its activity, for example by interacting with CREB
and thus eliciting activation (Chahrour et al., 2008).
In Rett’s syndrome, MeCP2 stands as the key DNA-binding
‘‘hook’’ to bring the repressive chromatin remodeling machinery
to target loci. In Rubinstein-Taybi syndrome (RSTS), character-
ized by mental retardation and developmental abnormalities,
the DNA-binding hook is provided by CREB. Phosphorylation
of CREB leads to CBP recruitment and activation of target
promoters. Causative mutations in RSTS map to the CBP gene
and may result in impairment of HAT activity (Murata et al.,
2001). Mice haploinsufficient for CBP display impaired cognitive
function, altered neuronal plasticity, and aberrant histone acety-
lation at target promoters (Alarcon et al., 2004; Korzus et al.,
2004). Interestingly, the behavioral symptoms can be amelio-
rated by administration of HDAC inhibitors (Vo and Goodman,
2001).
Additional examples show how HAT activity may be modulated
in pathological conditions because of unique interaction between
epigenetic regulators. A polyglutamine-expanded protein, spino-
cerebellar ataxia-7, regulates several HAT complexes (McMahon
et al., 2005; Palhan et al., 2005). The degree of polyglutamine
expansion correlates with the impairment of HAT activity, which
may, in turn, correlate with disease progression.
Docking of effector proteins, especially proteins containing
modules that bind to more stable methyl marks, is a rapidly
expanding area of chromatin biology (Ruthenburg et al., 2007a).
Equally exciting are ‘‘cross-talk’’ mechanisms wherein an adja-
cent or nearby modification can affect histone modifications on
‘‘cis’’ or ‘‘trans’’ tails (Briggs et al., 2002; Fischle et al., 2003).
For example, binding of HP1 to H3K9 methyl marks is regulated
by phosphorylation at the adjacent H3S10 (Figure 3) in what has
been referred to as ‘‘methyl/phos switching’’ (Fischle et al.,
2003). Interestingly, H3S10 phosphorylation can be induced
during mitosis or during immediate-early gene activation, elicited
by distinct kinases (Nowak and Corces, 2004). One kinase that
induces H3S10 phosphorylation during gene activation is
Rsk2, a kinase causally linked to Coffin-Lowry syndrome,
a type of human mental retardation (Sassone-Corsi et al.,
1999). Chromatin changes, in part brought about by H3S10
phosphorylation, have been directly demonstrated in hippo-
campal neurons (Crosio et al., 2003), leading to wider specula-
tions that chromatin remodeling could contribute to learning
and memory. Similar conclusions have been reached using
HDAC inhibitors (Fischer et al., 2007). These studies cast new
light on using ‘‘epigenetic therapies’’ to develop strategies for
neuronal dysfunctions, an approach that has proved effective
in the treatment of cancer (Jones and Baylin, 2007).
Summary, Conclusions, and Future Challenges
Remarkable progress has been made in documenting marks,
writers, readers, and erasers of a still incompletely defined
epigenetic histone code. While many questions remain, several
trends and conclusions can be reached. An elaborate series of
concerted enzymatic reactions remodel chromatin, leading to
the generation and maintenance of quasi-stable epigenetic
states. For example, HDAC recruitment to chromatin targets
could be considered a late step in a silencing pathway wherein970 Neuron 60, December 26, 2008 ª2008 Elsevier Inc.removal of acetyl groups from histone lysines, leading to the
re-establishment of positive charge, causes condensation of
the chromatin fiber in what is considered ‘‘cis mechanisms.’’
However, HDACs might also act earlier in a silencing pathway,
‘‘resetting’’ a particular lysine for subsequent methylation by
HMTs that, in turn, serve as docking surfaces for methyl-binding
effectors in what is being referred to as ‘‘trans mechanisms.’’
Other variations on this general theme may apply. For example,
acetylation may be used to recruit downstream machinery (acti-
vating or repressive) through bromodomain recognition or other
mechanisms. The general concept of multivalency in chromatin,
the combinatorial association of multiple ‘‘Velcro’’ modules to
bring about distinct effector:chromatin interactions, promises
to be an exciting area of future work (Ruthenburg et al.,
2007a). Early glimpses of this strategy at work have already
been reported (Li et al., 2007).
How do epigenetic signals translate into short-term versus
long-term memory effects in the nervous system? We favor
a scenario where neuronal-specific transcription factors recruit
chromatin remodeling activities that then lock in positive or nega-
tive epigenetic states. We like to speculate that more stable, non-
charge-altering modifications, such as methylation of DNA or
histones, participate in ‘‘lock-down’’ activities by engaging chro-
matin-opening or chromatin-closing effectors. In this view, highly
reversible modifications, such as acetylation and phosphoryla-
tion, may act as the dynamic ‘‘on-off switches’’ in response to
changing conditions and environmental cues (Figure 7).
However, much of biology, particularly that displayed by multicel-
lular organisms, requires less ‘‘black versus white’’ outputs and
rather gradual, ‘‘gray’’ responses. Here, we propose that ‘‘poly-
modifications,’’ like polyubiquitylation, etc., may be more in
keeping with graded responses. While well-documented in path-
ways of protein degradation, polymodifications should receive
more attention in chromatin biology (Verhey and Gaertig, 2007),
not only because of their biological significance, but also since
they may identify novel avenues of pharmacological intervention.
Considerable progress has been made in identifying chro-
matin-binding modules that function to read selective chromatin
marks. Less clear are functions of adding (or removing) chro-
matin-binding modules to nonhistone proteins. We note that
many chromatin-modifying enzymes (writers) also contain
reading modules, suggesting that the writing and reading of
epigenetic marks may work together in bringing about defined
chromatin states. Along this line, multiple prion-like domains
(glutamine- and asparagine-rich domains) have been noted in
Polycomb, leading to provocative suggestions that ‘‘self-aggre-
gation’’ properties may exist in chromatin regulators to carry or
to propagate long-term ‘‘memory formation and transcriptional
memory’’ through altered chromatin conformational states
(Shorter and Lindquist, 2005).
Finally, is there an epigenetic-based chromatin remodeling
process that serves to ‘‘shape’’ or to ‘‘mold’’ the landscape of
our genome as it deals with environmental cues? It may not be
a coincidence that many well-studied chromatin-modifying
enzymes are regulated by, or use directly as substrates, key
intermediates from central metabolism. Acetyl-coenzyme A is
required for most known HAT activities, while certain HDACs
are regulated by nicotinamide. S-adenyosyl methonine is
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histone demethylases. We predict that other ‘‘exotic’’ enzyme
systems will be uncovered that function to regulate chromatin
output following instructions from the environment. It follows
that diet, vitamin intake (or depletion), calorie restriction, oxida-
tive stress, aging, etc., will contribute to and impact epigenetic
signatures (DNA and histone) in ways that have yet to be fully
determined (Denu, 2007). Moreover, nonhistone proteins, in
some cases, those of cytosolic origin, will be critical substrates
that are only beginning to receive much-needed attention. Deter-
mining how this overall regulation impinges directly on neuronal
function, survival, and regeneration remains a worthwhile chal-
lenge for future studies. Finding the ‘‘writers,’’ ‘‘erasers,’’
‘‘readers,’’ and ‘‘interpreters’’ of this ‘‘epigenetic language’’ will
keep neurobiologists, as well as many other biologists, busy
for years to come.
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